Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

S&P ASX All Technology

US Dollar vs AUD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

null

Viridian Therapeutics (NASDAQ:VRDN)
Historical Stock Chart
From Jun 2024 to Jul 2024

Click Here for more Viridian Therapeutics Charts.

Viridian Therapeutics (NASDAQ:VRDN)
Historical Stock Chart
From Jul 2023 to Jul 2024

Click Here for more Viridian Therapeutics Charts.

Viridian Therapeutics Inc News

Viridian Therapeutics Announces Details of Subcutaneous VRDN-003 Phase 3 Clinical Program for Patients with Active and Chronic Moderate-to-Severe Thyroid Eye Disease
Tuesday 11 June 2024 (3 weeks ago) • Business Wire

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Monday 10 June 2024 (3 weeks ago) • Edgar (US Regulatory)

Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Friday 7 June 2024 (3 weeks ago) • Business Wire

Viridian Therapeutics Announces Participation in Upcoming June Investor Conferences
Friday 31 May 2024 (1 month ago) • Business Wire

Viridian Therapeutics to Participate in Upcoming May Investor Conferences
Friday 10 May 2024 (2 months ago) • Business Wire

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Wednesday 8 May 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 8 May 2024 (2 months ago) • Edgar (US Regulatory)

Viridian Therapeutics Highlights Recent Progress and Reports First Quarter 2024 Financial Results
Wednesday 8 May 2024 (2 months ago) • Business Wire

Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Friday 3 May 2024 (2 months ago) • Business Wire

Viridian Therapeutics to Webcast First Quarter 2024 Financial Results on May 8, 2024
Monday 29 April 2024 (2 months ago) • Business Wire

Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Friday 5 April 2024 (3 months ago) • Business Wire

Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Thursday 7 March 2024 (4 months ago) • Business Wire

More Viridian Therapeutics Inc News Articles

UNION Protocol Governance Token

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions